Skip to content
  • French
  • English
  • Dutch
  • German
Delbert Pharma Logo Delbert Pharma Logo Delbert Pharma Logo
  • The Laboratory
  • Our Vision
  • Expertise
  • Products
  • Partners
  • News
  • Contact

Transfert de la distribution de certaines présentations d’Augmentin injectable vers les Laboratoires Delbert

Transfert de la distribution de certaines présentations d’Augmentin injectable vers les Laboratoires Delbert
Letter Augmentin IV transfer from GSK to Delbert
edv2022-01-14T14:49:50+00:00July 30th, 2021|

Actualités / News

  • Availability of XYLLOMAC® 1g, powder for solution for injection/IM-IV infusion, box of 1, in pharmacies 13/12/2023
  • Commercialisation of LORAZEPAM XILMAC® 4mg/ml, solution for injection, in France 06/11/2023
  • Availability of Ceplene® 0.5mg/0.5ml, solution for injection (Histamine dihydrochloride), in Germany and Austria 09/10/2023
  • Availability of Prostaphlin® 1000 mg for Czech market 26/01/2023
  • Commercialization of amoxicilline in Ireland 16/01/2023
  • THE LABORATOIRES DELBERT ANNOUNCES A SERVICES AGREEMENT WITH IBI 30/11/2022
  • Acquisition de TERALITHE® par les Laboratoires Delbert 05/07/2022
  • Acquisition of TERALITHE® by the Laboratoires Delbert 17/05/2022
  • Laboratoires Delbert – Help to Ukraine 14/04/2022
  • Augmentin® injectable devient Levmentin® : informations et dates de mise à disposition 07/03/2022
Logo Laboratoires Delbert

49, rue Rouelle
75015 Paris
France
Phone + 33 1 46 99 68 20

Download the company information sheet of Delbert Pharma

  • Terms & Conditions
  • Privacy Policy
  • Contact
All rights reserved to the Laboratoires Delbert© . RCS Paris 443 960 570 - SAS with capital of 217 928 €
Page load link
  • French
  • English
  • Dutch
  • German
By continuing to browse, you accept the use of third-party services that may install cookiesOKNoprivacy policy
Go to Top